Ali Jane Piper, MD | |
1500 S 48th St Ste 800, Lincoln, NE 68506-1200 | |
(402) 483-8600 | |
(402) 483-8689 |
Full Name | Ali Jane Piper |
---|---|
Gender | Female |
Speciality | Pulmonary Disease |
Experience | 12 Years |
Location | 1500 S 48th St Ste 800, Lincoln, Nebraska |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1396009031 | NPI | - | NPPES |
10026942808 | Medicaid | NE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0200X | Internal Medicine - Critical Care Medicine | 28537 (Nebraska) | Secondary |
207RP1001X | Internal Medicine - Pulmonary Disease | 28537 (Nebraska) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Aseracare Hospice | Lincoln, NE | Hospice |
Bryan Medical Center | Lincoln, NE | Hospital |
Johnson County Hospital | Tecumseh, NE | Hospital |
Chi Health St. Elizabeth | Lincoln, NE | Hospital |
Great Plains Health | North platte, NE | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Beatrice Community Hospital And Health Center Inc | 1951208222 | 57 |
Bryan Hospital Kearney | 5991195547 | 91 |
Community Memorial Hospital District | 7517856859 | 24 |
Grand Island Regional Medical Center | 0143659508 | 11 |
Nebraska Pulmonary Specialties Llc | 3072412881 | 30 |
North Platte Nebraska Hospital Corporation | 6507856697 | 181 |
News Archive
Mylan Inc. today announced that its subsidiary Bioniche Pharma received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Fludarabine Phosphate Injection USP, 25 mg/mL, packaged in 50 mg/2 mL Single-dose Vials. The product was determined to be bioequivalent and, therefore, therapeutically equivalent to Teva Parenteral's Fludarabine Phosphate Injection USP, 25 mg/mL, a chemotherapy medication for B-cell chronic lymphocytic leukemia (CLL).
Researchers at the University of Texas M. D. Anderson Cancer Center have found a protein that enables cellular survival during periods of low oxygen, or hypoxia, which also is key for development of many kinds of cancer.
The sensors measured the galvanic skin response (GSR) of participants then wirelessly transmitted the data to a server which processed the data to generate a quick, read on the whole audience's responses.
Screening for Mental Health, Inc. (SMH) today announced that they have received funding from the Department of Defense (DoD) to continue their work with Military Pathways™, a mental health awareness and education program that offers free, anonymous mental health self-assessments to veterans and personnel from all branches of the military as well as their families.
The experimental antiviral drug MK-4482 significantly decreased levels of virus and disease damage in the lungs of hamsters treated for SARS-CoV-2 infection, according to a new study from National Institutes of Health scientists.
› Verified 8 days ago
Entity Name | The Mary Lanning Memorial Hospital Association |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1760530216 PECOS PAC ID: 4587575550 Enrollment ID: O20031105000492 |
News Archive
Mylan Inc. today announced that its subsidiary Bioniche Pharma received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Fludarabine Phosphate Injection USP, 25 mg/mL, packaged in 50 mg/2 mL Single-dose Vials. The product was determined to be bioequivalent and, therefore, therapeutically equivalent to Teva Parenteral's Fludarabine Phosphate Injection USP, 25 mg/mL, a chemotherapy medication for B-cell chronic lymphocytic leukemia (CLL).
Researchers at the University of Texas M. D. Anderson Cancer Center have found a protein that enables cellular survival during periods of low oxygen, or hypoxia, which also is key for development of many kinds of cancer.
The sensors measured the galvanic skin response (GSR) of participants then wirelessly transmitted the data to a server which processed the data to generate a quick, read on the whole audience's responses.
Screening for Mental Health, Inc. (SMH) today announced that they have received funding from the Department of Defense (DoD) to continue their work with Military Pathways™, a mental health awareness and education program that offers free, anonymous mental health self-assessments to veterans and personnel from all branches of the military as well as their families.
The experimental antiviral drug MK-4482 significantly decreased levels of virus and disease damage in the lungs of hamsters treated for SARS-CoV-2 infection, according to a new study from National Institutes of Health scientists.
› Verified 8 days ago
Entity Name | The Physician Network |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1437184652 PECOS PAC ID: 3476453267 Enrollment ID: O20040128001100 |
News Archive
Mylan Inc. today announced that its subsidiary Bioniche Pharma received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Fludarabine Phosphate Injection USP, 25 mg/mL, packaged in 50 mg/2 mL Single-dose Vials. The product was determined to be bioequivalent and, therefore, therapeutically equivalent to Teva Parenteral's Fludarabine Phosphate Injection USP, 25 mg/mL, a chemotherapy medication for B-cell chronic lymphocytic leukemia (CLL).
Researchers at the University of Texas M. D. Anderson Cancer Center have found a protein that enables cellular survival during periods of low oxygen, or hypoxia, which also is key for development of many kinds of cancer.
The sensors measured the galvanic skin response (GSR) of participants then wirelessly transmitted the data to a server which processed the data to generate a quick, read on the whole audience's responses.
Screening for Mental Health, Inc. (SMH) today announced that they have received funding from the Department of Defense (DoD) to continue their work with Military Pathways™, a mental health awareness and education program that offers free, anonymous mental health self-assessments to veterans and personnel from all branches of the military as well as their families.
The experimental antiviral drug MK-4482 significantly decreased levels of virus and disease damage in the lungs of hamsters treated for SARS-CoV-2 infection, according to a new study from National Institutes of Health scientists.
› Verified 8 days ago
Entity Name | Community Memorial Hospital District |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1336155134 PECOS PAC ID: 7517856859 Enrollment ID: O20040313000441 |
News Archive
Mylan Inc. today announced that its subsidiary Bioniche Pharma received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Fludarabine Phosphate Injection USP, 25 mg/mL, packaged in 50 mg/2 mL Single-dose Vials. The product was determined to be bioequivalent and, therefore, therapeutically equivalent to Teva Parenteral's Fludarabine Phosphate Injection USP, 25 mg/mL, a chemotherapy medication for B-cell chronic lymphocytic leukemia (CLL).
Researchers at the University of Texas M. D. Anderson Cancer Center have found a protein that enables cellular survival during periods of low oxygen, or hypoxia, which also is key for development of many kinds of cancer.
The sensors measured the galvanic skin response (GSR) of participants then wirelessly transmitted the data to a server which processed the data to generate a quick, read on the whole audience's responses.
Screening for Mental Health, Inc. (SMH) today announced that they have received funding from the Department of Defense (DoD) to continue their work with Military Pathways™, a mental health awareness and education program that offers free, anonymous mental health self-assessments to veterans and personnel from all branches of the military as well as their families.
The experimental antiviral drug MK-4482 significantly decreased levels of virus and disease damage in the lungs of hamsters treated for SARS-CoV-2 infection, according to a new study from National Institutes of Health scientists.
› Verified 8 days ago
Entity Name | Columbus Community Hospital Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1427152131 PECOS PAC ID: 7517954944 Enrollment ID: O20040428000541 |
News Archive
Mylan Inc. today announced that its subsidiary Bioniche Pharma received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Fludarabine Phosphate Injection USP, 25 mg/mL, packaged in 50 mg/2 mL Single-dose Vials. The product was determined to be bioequivalent and, therefore, therapeutically equivalent to Teva Parenteral's Fludarabine Phosphate Injection USP, 25 mg/mL, a chemotherapy medication for B-cell chronic lymphocytic leukemia (CLL).
Researchers at the University of Texas M. D. Anderson Cancer Center have found a protein that enables cellular survival during periods of low oxygen, or hypoxia, which also is key for development of many kinds of cancer.
The sensors measured the galvanic skin response (GSR) of participants then wirelessly transmitted the data to a server which processed the data to generate a quick, read on the whole audience's responses.
Screening for Mental Health, Inc. (SMH) today announced that they have received funding from the Department of Defense (DoD) to continue their work with Military Pathways™, a mental health awareness and education program that offers free, anonymous mental health self-assessments to veterans and personnel from all branches of the military as well as their families.
The experimental antiviral drug MK-4482 significantly decreased levels of virus and disease damage in the lungs of hamsters treated for SARS-CoV-2 infection, according to a new study from National Institutes of Health scientists.
› Verified 8 days ago
Entity Name | North Platte Nebraska Hospital Corporation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1700855533 PECOS PAC ID: 6507856697 Enrollment ID: O20040512000889 |
News Archive
Mylan Inc. today announced that its subsidiary Bioniche Pharma received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Fludarabine Phosphate Injection USP, 25 mg/mL, packaged in 50 mg/2 mL Single-dose Vials. The product was determined to be bioequivalent and, therefore, therapeutically equivalent to Teva Parenteral's Fludarabine Phosphate Injection USP, 25 mg/mL, a chemotherapy medication for B-cell chronic lymphocytic leukemia (CLL).
Researchers at the University of Texas M. D. Anderson Cancer Center have found a protein that enables cellular survival during periods of low oxygen, or hypoxia, which also is key for development of many kinds of cancer.
The sensors measured the galvanic skin response (GSR) of participants then wirelessly transmitted the data to a server which processed the data to generate a quick, read on the whole audience's responses.
Screening for Mental Health, Inc. (SMH) today announced that they have received funding from the Department of Defense (DoD) to continue their work with Military Pathways™, a mental health awareness and education program that offers free, anonymous mental health self-assessments to veterans and personnel from all branches of the military as well as their families.
The experimental antiviral drug MK-4482 significantly decreased levels of virus and disease damage in the lungs of hamsters treated for SARS-CoV-2 infection, according to a new study from National Institutes of Health scientists.
› Verified 8 days ago
Entity Name | Providence Medical Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1801867494 PECOS PAC ID: 4587629928 Enrollment ID: O20041124000342 |
News Archive
Mylan Inc. today announced that its subsidiary Bioniche Pharma received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Fludarabine Phosphate Injection USP, 25 mg/mL, packaged in 50 mg/2 mL Single-dose Vials. The product was determined to be bioequivalent and, therefore, therapeutically equivalent to Teva Parenteral's Fludarabine Phosphate Injection USP, 25 mg/mL, a chemotherapy medication for B-cell chronic lymphocytic leukemia (CLL).
Researchers at the University of Texas M. D. Anderson Cancer Center have found a protein that enables cellular survival during periods of low oxygen, or hypoxia, which also is key for development of many kinds of cancer.
The sensors measured the galvanic skin response (GSR) of participants then wirelessly transmitted the data to a server which processed the data to generate a quick, read on the whole audience's responses.
Screening for Mental Health, Inc. (SMH) today announced that they have received funding from the Department of Defense (DoD) to continue their work with Military Pathways™, a mental health awareness and education program that offers free, anonymous mental health self-assessments to veterans and personnel from all branches of the military as well as their families.
The experimental antiviral drug MK-4482 significantly decreased levels of virus and disease damage in the lungs of hamsters treated for SARS-CoV-2 infection, according to a new study from National Institutes of Health scientists.
› Verified 8 days ago
Entity Name | Harlan County Health System |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1124035225 PECOS PAC ID: 8325088214 Enrollment ID: O20050510000912 |
News Archive
Mylan Inc. today announced that its subsidiary Bioniche Pharma received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Fludarabine Phosphate Injection USP, 25 mg/mL, packaged in 50 mg/2 mL Single-dose Vials. The product was determined to be bioequivalent and, therefore, therapeutically equivalent to Teva Parenteral's Fludarabine Phosphate Injection USP, 25 mg/mL, a chemotherapy medication for B-cell chronic lymphocytic leukemia (CLL).
Researchers at the University of Texas M. D. Anderson Cancer Center have found a protein that enables cellular survival during periods of low oxygen, or hypoxia, which also is key for development of many kinds of cancer.
The sensors measured the galvanic skin response (GSR) of participants then wirelessly transmitted the data to a server which processed the data to generate a quick, read on the whole audience's responses.
Screening for Mental Health, Inc. (SMH) today announced that they have received funding from the Department of Defense (DoD) to continue their work with Military Pathways™, a mental health awareness and education program that offers free, anonymous mental health self-assessments to veterans and personnel from all branches of the military as well as their families.
The experimental antiviral drug MK-4482 significantly decreased levels of virus and disease damage in the lungs of hamsters treated for SARS-CoV-2 infection, according to a new study from National Institutes of Health scientists.
› Verified 8 days ago
Entity Name | Johnson County Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1780895110 PECOS PAC ID: 4688583644 Enrollment ID: O20070613000738 |
News Archive
Mylan Inc. today announced that its subsidiary Bioniche Pharma received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Fludarabine Phosphate Injection USP, 25 mg/mL, packaged in 50 mg/2 mL Single-dose Vials. The product was determined to be bioequivalent and, therefore, therapeutically equivalent to Teva Parenteral's Fludarabine Phosphate Injection USP, 25 mg/mL, a chemotherapy medication for B-cell chronic lymphocytic leukemia (CLL).
Researchers at the University of Texas M. D. Anderson Cancer Center have found a protein that enables cellular survival during periods of low oxygen, or hypoxia, which also is key for development of many kinds of cancer.
The sensors measured the galvanic skin response (GSR) of participants then wirelessly transmitted the data to a server which processed the data to generate a quick, read on the whole audience's responses.
Screening for Mental Health, Inc. (SMH) today announced that they have received funding from the Department of Defense (DoD) to continue their work with Military Pathways™, a mental health awareness and education program that offers free, anonymous mental health self-assessments to veterans and personnel from all branches of the military as well as their families.
The experimental antiviral drug MK-4482 significantly decreased levels of virus and disease damage in the lungs of hamsters treated for SARS-CoV-2 infection, according to a new study from National Institutes of Health scientists.
› Verified 8 days ago
Entity Name | Johnson County Hospital |
---|---|
Entity Type | Part A Provider - Critical Access Hospital |
Entity Identifiers | NPI Number: 1285624825 PECOS PAC ID: 4688583644 Enrollment ID: O20071129000037 |
News Archive
Mylan Inc. today announced that its subsidiary Bioniche Pharma received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Fludarabine Phosphate Injection USP, 25 mg/mL, packaged in 50 mg/2 mL Single-dose Vials. The product was determined to be bioequivalent and, therefore, therapeutically equivalent to Teva Parenteral's Fludarabine Phosphate Injection USP, 25 mg/mL, a chemotherapy medication for B-cell chronic lymphocytic leukemia (CLL).
Researchers at the University of Texas M. D. Anderson Cancer Center have found a protein that enables cellular survival during periods of low oxygen, or hypoxia, which also is key for development of many kinds of cancer.
The sensors measured the galvanic skin response (GSR) of participants then wirelessly transmitted the data to a server which processed the data to generate a quick, read on the whole audience's responses.
Screening for Mental Health, Inc. (SMH) today announced that they have received funding from the Department of Defense (DoD) to continue their work with Military Pathways™, a mental health awareness and education program that offers free, anonymous mental health self-assessments to veterans and personnel from all branches of the military as well as their families.
The experimental antiviral drug MK-4482 significantly decreased levels of virus and disease damage in the lungs of hamsters treated for SARS-CoV-2 infection, according to a new study from National Institutes of Health scientists.
› Verified 8 days ago
Entity Name | Memorial Community Health Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1881603850 PECOS PAC ID: 1355394040 Enrollment ID: O20100213000119 |
News Archive
Mylan Inc. today announced that its subsidiary Bioniche Pharma received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Fludarabine Phosphate Injection USP, 25 mg/mL, packaged in 50 mg/2 mL Single-dose Vials. The product was determined to be bioequivalent and, therefore, therapeutically equivalent to Teva Parenteral's Fludarabine Phosphate Injection USP, 25 mg/mL, a chemotherapy medication for B-cell chronic lymphocytic leukemia (CLL).
Researchers at the University of Texas M. D. Anderson Cancer Center have found a protein that enables cellular survival during periods of low oxygen, or hypoxia, which also is key for development of many kinds of cancer.
The sensors measured the galvanic skin response (GSR) of participants then wirelessly transmitted the data to a server which processed the data to generate a quick, read on the whole audience's responses.
Screening for Mental Health, Inc. (SMH) today announced that they have received funding from the Department of Defense (DoD) to continue their work with Military Pathways™, a mental health awareness and education program that offers free, anonymous mental health self-assessments to veterans and personnel from all branches of the military as well as their families.
The experimental antiviral drug MK-4482 significantly decreased levels of virus and disease damage in the lungs of hamsters treated for SARS-CoV-2 infection, according to a new study from National Institutes of Health scientists.
› Verified 8 days ago
Entity Name | Howard County Medical Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1154626216 PECOS PAC ID: 5698775849 Enrollment ID: O20110614000460 |
News Archive
Mylan Inc. today announced that its subsidiary Bioniche Pharma received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Fludarabine Phosphate Injection USP, 25 mg/mL, packaged in 50 mg/2 mL Single-dose Vials. The product was determined to be bioequivalent and, therefore, therapeutically equivalent to Teva Parenteral's Fludarabine Phosphate Injection USP, 25 mg/mL, a chemotherapy medication for B-cell chronic lymphocytic leukemia (CLL).
Researchers at the University of Texas M. D. Anderson Cancer Center have found a protein that enables cellular survival during periods of low oxygen, or hypoxia, which also is key for development of many kinds of cancer.
The sensors measured the galvanic skin response (GSR) of participants then wirelessly transmitted the data to a server which processed the data to generate a quick, read on the whole audience's responses.
Screening for Mental Health, Inc. (SMH) today announced that they have received funding from the Department of Defense (DoD) to continue their work with Military Pathways™, a mental health awareness and education program that offers free, anonymous mental health self-assessments to veterans and personnel from all branches of the military as well as their families.
The experimental antiviral drug MK-4482 significantly decreased levels of virus and disease damage in the lungs of hamsters treated for SARS-CoV-2 infection, according to a new study from National Institutes of Health scientists.
› Verified 8 days ago
Entity Name | Nebraska Pulmonary Specialties Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1669728457 PECOS PAC ID: 3072412881 Enrollment ID: O20121026000145 |
News Archive
Mylan Inc. today announced that its subsidiary Bioniche Pharma received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Fludarabine Phosphate Injection USP, 25 mg/mL, packaged in 50 mg/2 mL Single-dose Vials. The product was determined to be bioequivalent and, therefore, therapeutically equivalent to Teva Parenteral's Fludarabine Phosphate Injection USP, 25 mg/mL, a chemotherapy medication for B-cell chronic lymphocytic leukemia (CLL).
Researchers at the University of Texas M. D. Anderson Cancer Center have found a protein that enables cellular survival during periods of low oxygen, or hypoxia, which also is key for development of many kinds of cancer.
The sensors measured the galvanic skin response (GSR) of participants then wirelessly transmitted the data to a server which processed the data to generate a quick, read on the whole audience's responses.
Screening for Mental Health, Inc. (SMH) today announced that they have received funding from the Department of Defense (DoD) to continue their work with Military Pathways™, a mental health awareness and education program that offers free, anonymous mental health self-assessments to veterans and personnel from all branches of the military as well as their families.
The experimental antiviral drug MK-4482 significantly decreased levels of virus and disease damage in the lungs of hamsters treated for SARS-CoV-2 infection, according to a new study from National Institutes of Health scientists.
› Verified 8 days ago
Entity Name | Beatrice Community Hospital & Health Center Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1922111855 PECOS PAC ID: 1951208222 Enrollment ID: O20121214000477 |
News Archive
Mylan Inc. today announced that its subsidiary Bioniche Pharma received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Fludarabine Phosphate Injection USP, 25 mg/mL, packaged in 50 mg/2 mL Single-dose Vials. The product was determined to be bioequivalent and, therefore, therapeutically equivalent to Teva Parenteral's Fludarabine Phosphate Injection USP, 25 mg/mL, a chemotherapy medication for B-cell chronic lymphocytic leukemia (CLL).
Researchers at the University of Texas M. D. Anderson Cancer Center have found a protein that enables cellular survival during periods of low oxygen, or hypoxia, which also is key for development of many kinds of cancer.
The sensors measured the galvanic skin response (GSR) of participants then wirelessly transmitted the data to a server which processed the data to generate a quick, read on the whole audience's responses.
Screening for Mental Health, Inc. (SMH) today announced that they have received funding from the Department of Defense (DoD) to continue their work with Military Pathways™, a mental health awareness and education program that offers free, anonymous mental health self-assessments to veterans and personnel from all branches of the military as well as their families.
The experimental antiviral drug MK-4482 significantly decreased levels of virus and disease damage in the lungs of hamsters treated for SARS-CoV-2 infection, according to a new study from National Institutes of Health scientists.
› Verified 8 days ago
Entity Name | Grand Island Regional Medical Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1225658495 PECOS PAC ID: 0143659508 Enrollment ID: O20200904000271 |
News Archive
Mylan Inc. today announced that its subsidiary Bioniche Pharma received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Fludarabine Phosphate Injection USP, 25 mg/mL, packaged in 50 mg/2 mL Single-dose Vials. The product was determined to be bioequivalent and, therefore, therapeutically equivalent to Teva Parenteral's Fludarabine Phosphate Injection USP, 25 mg/mL, a chemotherapy medication for B-cell chronic lymphocytic leukemia (CLL).
Researchers at the University of Texas M. D. Anderson Cancer Center have found a protein that enables cellular survival during periods of low oxygen, or hypoxia, which also is key for development of many kinds of cancer.
The sensors measured the galvanic skin response (GSR) of participants then wirelessly transmitted the data to a server which processed the data to generate a quick, read on the whole audience's responses.
Screening for Mental Health, Inc. (SMH) today announced that they have received funding from the Department of Defense (DoD) to continue their work with Military Pathways™, a mental health awareness and education program that offers free, anonymous mental health self-assessments to veterans and personnel from all branches of the military as well as their families.
The experimental antiviral drug MK-4482 significantly decreased levels of virus and disease damage in the lungs of hamsters treated for SARS-CoV-2 infection, according to a new study from National Institutes of Health scientists.
› Verified 8 days ago
Entity Name | Chi Health Clinic Specialty Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1285138065 PECOS PAC ID: 4789098443 Enrollment ID: O20210121000492 |
News Archive
Mylan Inc. today announced that its subsidiary Bioniche Pharma received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Fludarabine Phosphate Injection USP, 25 mg/mL, packaged in 50 mg/2 mL Single-dose Vials. The product was determined to be bioequivalent and, therefore, therapeutically equivalent to Teva Parenteral's Fludarabine Phosphate Injection USP, 25 mg/mL, a chemotherapy medication for B-cell chronic lymphocytic leukemia (CLL).
Researchers at the University of Texas M. D. Anderson Cancer Center have found a protein that enables cellular survival during periods of low oxygen, or hypoxia, which also is key for development of many kinds of cancer.
The sensors measured the galvanic skin response (GSR) of participants then wirelessly transmitted the data to a server which processed the data to generate a quick, read on the whole audience's responses.
Screening for Mental Health, Inc. (SMH) today announced that they have received funding from the Department of Defense (DoD) to continue their work with Military Pathways™, a mental health awareness and education program that offers free, anonymous mental health self-assessments to veterans and personnel from all branches of the military as well as their families.
The experimental antiviral drug MK-4482 significantly decreased levels of virus and disease damage in the lungs of hamsters treated for SARS-CoV-2 infection, according to a new study from National Institutes of Health scientists.
› Verified 8 days ago
Entity Name | Bryan Hospital Kearney |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1033875380 PECOS PAC ID: 5991195547 Enrollment ID: O20211214002678 |
News Archive
Mylan Inc. today announced that its subsidiary Bioniche Pharma received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Fludarabine Phosphate Injection USP, 25 mg/mL, packaged in 50 mg/2 mL Single-dose Vials. The product was determined to be bioequivalent and, therefore, therapeutically equivalent to Teva Parenteral's Fludarabine Phosphate Injection USP, 25 mg/mL, a chemotherapy medication for B-cell chronic lymphocytic leukemia (CLL).
Researchers at the University of Texas M. D. Anderson Cancer Center have found a protein that enables cellular survival during periods of low oxygen, or hypoxia, which also is key for development of many kinds of cancer.
The sensors measured the galvanic skin response (GSR) of participants then wirelessly transmitted the data to a server which processed the data to generate a quick, read on the whole audience's responses.
Screening for Mental Health, Inc. (SMH) today announced that they have received funding from the Department of Defense (DoD) to continue their work with Military Pathways™, a mental health awareness and education program that offers free, anonymous mental health self-assessments to veterans and personnel from all branches of the military as well as their families.
The experimental antiviral drug MK-4482 significantly decreased levels of virus and disease damage in the lungs of hamsters treated for SARS-CoV-2 infection, according to a new study from National Institutes of Health scientists.
› Verified 8 days ago
Entity Name | Clay County Medical Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1134163389 PECOS PAC ID: 6901959436 Enrollment ID: O20220926000419 |
News Archive
Mylan Inc. today announced that its subsidiary Bioniche Pharma received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Fludarabine Phosphate Injection USP, 25 mg/mL, packaged in 50 mg/2 mL Single-dose Vials. The product was determined to be bioequivalent and, therefore, therapeutically equivalent to Teva Parenteral's Fludarabine Phosphate Injection USP, 25 mg/mL, a chemotherapy medication for B-cell chronic lymphocytic leukemia (CLL).
Researchers at the University of Texas M. D. Anderson Cancer Center have found a protein that enables cellular survival during periods of low oxygen, or hypoxia, which also is key for development of many kinds of cancer.
The sensors measured the galvanic skin response (GSR) of participants then wirelessly transmitted the data to a server which processed the data to generate a quick, read on the whole audience's responses.
Screening for Mental Health, Inc. (SMH) today announced that they have received funding from the Department of Defense (DoD) to continue their work with Military Pathways™, a mental health awareness and education program that offers free, anonymous mental health self-assessments to veterans and personnel from all branches of the military as well as their families.
The experimental antiviral drug MK-4482 significantly decreased levels of virus and disease damage in the lungs of hamsters treated for SARS-CoV-2 infection, according to a new study from National Institutes of Health scientists.
› Verified 8 days ago
Entity Name | Phillips County Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1639264492 PECOS PAC ID: 7012231251 Enrollment ID: O20230209000918 |
News Archive
Mylan Inc. today announced that its subsidiary Bioniche Pharma received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Fludarabine Phosphate Injection USP, 25 mg/mL, packaged in 50 mg/2 mL Single-dose Vials. The product was determined to be bioequivalent and, therefore, therapeutically equivalent to Teva Parenteral's Fludarabine Phosphate Injection USP, 25 mg/mL, a chemotherapy medication for B-cell chronic lymphocytic leukemia (CLL).
Researchers at the University of Texas M. D. Anderson Cancer Center have found a protein that enables cellular survival during periods of low oxygen, or hypoxia, which also is key for development of many kinds of cancer.
The sensors measured the galvanic skin response (GSR) of participants then wirelessly transmitted the data to a server which processed the data to generate a quick, read on the whole audience's responses.
Screening for Mental Health, Inc. (SMH) today announced that they have received funding from the Department of Defense (DoD) to continue their work with Military Pathways™, a mental health awareness and education program that offers free, anonymous mental health self-assessments to veterans and personnel from all branches of the military as well as their families.
The experimental antiviral drug MK-4482 significantly decreased levels of virus and disease damage in the lungs of hamsters treated for SARS-CoV-2 infection, according to a new study from National Institutes of Health scientists.
› Verified 8 days ago
Entity Name | Shelby County Chris A Myrtue Memorial Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1922184175 PECOS PAC ID: 5193619393 Enrollment ID: O20231101001600 |
News Archive
Mylan Inc. today announced that its subsidiary Bioniche Pharma received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Fludarabine Phosphate Injection USP, 25 mg/mL, packaged in 50 mg/2 mL Single-dose Vials. The product was determined to be bioequivalent and, therefore, therapeutically equivalent to Teva Parenteral's Fludarabine Phosphate Injection USP, 25 mg/mL, a chemotherapy medication for B-cell chronic lymphocytic leukemia (CLL).
Researchers at the University of Texas M. D. Anderson Cancer Center have found a protein that enables cellular survival during periods of low oxygen, or hypoxia, which also is key for development of many kinds of cancer.
The sensors measured the galvanic skin response (GSR) of participants then wirelessly transmitted the data to a server which processed the data to generate a quick, read on the whole audience's responses.
Screening for Mental Health, Inc. (SMH) today announced that they have received funding from the Department of Defense (DoD) to continue their work with Military Pathways™, a mental health awareness and education program that offers free, anonymous mental health self-assessments to veterans and personnel from all branches of the military as well as their families.
The experimental antiviral drug MK-4482 significantly decreased levels of virus and disease damage in the lungs of hamsters treated for SARS-CoV-2 infection, according to a new study from National Institutes of Health scientists.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Ali Jane Piper, MD 1500 S 48th St Ste 800, Lincoln, NE 68506-1200 Ph: (402) 483-8600 | Ali Jane Piper, MD 1500 S 48th St Ste 800, Lincoln, NE 68506-1200 Ph: (402) 483-8600 |
News Archive
Mylan Inc. today announced that its subsidiary Bioniche Pharma received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Fludarabine Phosphate Injection USP, 25 mg/mL, packaged in 50 mg/2 mL Single-dose Vials. The product was determined to be bioequivalent and, therefore, therapeutically equivalent to Teva Parenteral's Fludarabine Phosphate Injection USP, 25 mg/mL, a chemotherapy medication for B-cell chronic lymphocytic leukemia (CLL).
Researchers at the University of Texas M. D. Anderson Cancer Center have found a protein that enables cellular survival during periods of low oxygen, or hypoxia, which also is key for development of many kinds of cancer.
The sensors measured the galvanic skin response (GSR) of participants then wirelessly transmitted the data to a server which processed the data to generate a quick, read on the whole audience's responses.
Screening for Mental Health, Inc. (SMH) today announced that they have received funding from the Department of Defense (DoD) to continue their work with Military Pathways™, a mental health awareness and education program that offers free, anonymous mental health self-assessments to veterans and personnel from all branches of the military as well as their families.
The experimental antiviral drug MK-4482 significantly decreased levels of virus and disease damage in the lungs of hamsters treated for SARS-CoV-2 infection, according to a new study from National Institutes of Health scientists.
› Verified 8 days ago
Ted M Triggs, DO Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 555 S 70th St, Lincoln, NE 68510 Phone: 402-219-8747 Fax: 402-219-8748 | |
Joseph L Kummer, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1600 S 48th St, Suite 600, Lincoln, NE 68506 Phone: 402-483-3333 Fax: 402-483-3297 | |
Brenda Kay Bell, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1919 S 40th, Ste 207, Lincoln, NE 68506 Phone: 402-489-3383 Fax: 402-489-3789 | |
Scott Allen Heasty, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 2300 S 16th St, Lincoln, NE 68502 Phone: 402-481-4780 Fax: 402-481-5377 | |
Scott Charles Rasmussen, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 3901 Pine Lake Rd, Suite 220, Lincoln, NE 68516 Phone: 402-421-3240 Fax: 402-423-0739 | |
Jeffrey E Jarrett, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1500 S 48th St, Suite 800, Lincoln, NE 68506 Phone: 402-483-8600 Fax: 402-483-8689 | |
Tracy L Slocum Farritor, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 555 S 70th St, Lincoln, NE 68510 Phone: 402-219-8747 Fax: 402-219-8748 |